223 related articles for article (PubMed ID: 15616896)
1. Osteopenia: a bone disorder associated with diabetes mellitus.
Duarte VM; Ramos AM; Rezende LA; Macedo UB; Brandão-Neto J; Almeida MG; Rezende AA
J Bone Miner Metab; 2005; 23(1):58-68. PubMed ID: 15616896
[TBL] [Abstract][Full Text] [Related]
2. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.
Kemink SA; Hermus AR; Swinkels LM; Lutterman JA; Smals AG
J Endocrinol Invest; 2000 May; 23(5):295-303. PubMed ID: 10882147
[TBL] [Abstract][Full Text] [Related]
3. Amylin and bone metabolism in streptozotocin-induced diabetic rats.
Horcajada-Molteni MN; Chanteranne B; Lebecque P; Davicco MJ; Coxam V; Young A; Barlet JP
J Bone Miner Res; 2001 May; 16(5):958-65. PubMed ID: 11341342
[TBL] [Abstract][Full Text] [Related]
4. Effects of streptozotocin-induced diabetes mellitus on some bone turnover markers in the vertebrae of ovary-intact and ovariectomized adult rats.
Gopalakrishnan V; Arunakaran J; Aruldhas MM; Srinivasan N
Biochem Cell Biol; 2006 Oct; 84(5):728-36. PubMed ID: 17167536
[TBL] [Abstract][Full Text] [Related]
5. Effect of Cissus quadrangularis Linn on the development of osteopenia induced by ovariectomy in rats.
Potu BK; Nampurath GK; Rao MS; Bhat KM
Clin Ter; 2011; 162(4):307-12. PubMed ID: 21912817
[TBL] [Abstract][Full Text] [Related]
6. The influence of nitric oxide synthase inhibitor L-NAME on bones of male rats with streptozotocin-induced diabetes.
Broulík PD; Haluzík M; Skrha J
Physiol Res; 2003; 52(6):729-34. PubMed ID: 14640894
[TBL] [Abstract][Full Text] [Related]
7. Increased cathepsin K and tartrate-resistant acid phosphatase expression in bone of streptozotocin-induced diabetic rats.
Hie M; Shimono M; Fujii K; Tsukamoto I
Bone; 2007 Dec; 41(6):1045-50. PubMed ID: 17916452
[TBL] [Abstract][Full Text] [Related]
8. Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat.
Epstein S; Takizawa M; Stein B; Katz IA; Joffe II; Romero DF; Liang XG; Li M; Ke HZ; Jee WS
J Bone Miner Res; 1994 Apr; 9(4):557-66. PubMed ID: 8030444
[TBL] [Abstract][Full Text] [Related]
9. Low-level lifetime exposure to cadmium decreases skeletal mineralization and enhances bone loss in aged rats.
Brzóska MM; Moniuszko-Jakoniuk J
Bone; 2004 Nov; 35(5):1180-91. PubMed ID: 15542044
[TBL] [Abstract][Full Text] [Related]
10. Appliance-induced osteopenia of dentoalveolar bone in the rat: effect of reduced bone strains on serum bone markers and the multifunctional hormone leptin.
Vinoth JK; Patel KJ; Lih WS; Seow YS; Cao T; Meikle MC
Eur J Oral Sci; 2013 Dec; 121(6):517-24. PubMed ID: 24112221
[TBL] [Abstract][Full Text] [Related]
11. Amylin increases bone volume but cannot ameliorate diabetic osteopenia.
Romero DF; Bryer HP; Rucinski B; Isserow JA; Buchinsky FJ; Cvetkovic M; Liu CC; Epstein S
Calcif Tissue Int; 1995 Jan; 56(1):54-61. PubMed ID: 7796348
[TBL] [Abstract][Full Text] [Related]
12. Effects of treadmill exercise on bone mass, bone metabolism, and calciotropic hormones in young growing rats.
Iwamoto J; Shimamura C; Takeda T; Abe H; Ichimura S; Sato Y; Toyama Y
J Bone Miner Metab; 2004; 22(1):26-31. PubMed ID: 14691683
[TBL] [Abstract][Full Text] [Related]
13. Histomorphometric analysis of diabetic osteopenia in streptozotocin-induced diabetic mice: a possible role of oxidative stress.
Hamada Y; Kitazawa S; Kitazawa R; Fujii H; Kasuga M; Fukagawa M
Bone; 2007 May; 40(5):1408-14. PubMed ID: 17251074
[TBL] [Abstract][Full Text] [Related]
14. Delayed bone regeneration and low bone mass in a rat model of insulin-resistant type 2 diabetes mellitus is due to impaired osteoblast function.
Hamann C; Goettsch C; Mettelsiefen J; Henkenjohann V; Rauner M; Hempel U; Bernhardt R; Fratzl-Zelman N; Roschger P; Rammelt S; Günther KP; Hofbauer LC
Am J Physiol Endocrinol Metab; 2011 Dec; 301(6):E1220-8. PubMed ID: 21900121
[TBL] [Abstract][Full Text] [Related]
15. Running exercise for short duration increases bone mineral density of loaded long bones in young growing rats.
Hagihara Y; Nakajima A; Fukuda S; Goto S; Iida H; Yamazaki M
Tohoku J Exp Med; 2009 Oct; 219(2):139-43. PubMed ID: 19776531
[TBL] [Abstract][Full Text] [Related]
16. Bone mineral density measured by dual X-ray absorptiometry in Spanish patients with insulin-dependent diabetes mellitus.
Muñoz-Torres M; Jódar E; Escobar-Jiménez F; López-Ibarra PJ; Luna JD
Calcif Tissue Int; 1996 May; 58(5):316-9. PubMed ID: 8661964
[TBL] [Abstract][Full Text] [Related]
17. Bone loss in experimental diabetes. Comparison with the model of inflammation mediated osteopenia.
Hadjidakis D; Lempert UG; Minne HW; Ziegler R
Horm Metab Res; 1993 Feb; 25(2):77-81. PubMed ID: 8458612
[TBL] [Abstract][Full Text] [Related]
18. Increased bone resorption may play a crucial role in the occurrence of osteopenia in patients with type 2 diabetes: Possible involvement of accelerated polyol pathway in its pathogenesis.
Takizawa M; Suzuki K; Matsubayashi T; Kikuyama M; Suzuki H; Takahashi K; Katsuta H; Mitsuhashi J; Nishida S; Yamaguchi S; Yoshimoto K; Itagaki E; Ishida H
Diabetes Res Clin Pract; 2008 Oct; 82(1):119-26. PubMed ID: 18774197
[TBL] [Abstract][Full Text] [Related]
19. Brittle bones in spontaneously diabetic female rats cannot be predicted by bone mineral measurements: studies in diabetic and ovariectomized rats.
Verhaeghe J; Suiker AM; Einhorn TA; Geusens P; Visser WJ; Van Herck E; Van Bree R; Magitsky S; Bouillon R
J Bone Miner Res; 1994 Oct; 9(10):1657-67. PubMed ID: 7817814
[TBL] [Abstract][Full Text] [Related]
20. Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclastogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral density.
Suzuki K; Kurose T; Takizawa M; Maruyama M; Ushikawa K; Kikuyama M; Sugimoto C; Seino Y; Nagamatsu S; Ishida H
Diabetes Res Clin Pract; 2005 May; 68(2):117-25. PubMed ID: 15860239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
